ANTX

AN2 Therapeutics, Inc.

Phase 1 AI-extracted

oral AN2-502998

Chagas disease

Resolved

187days ago

Phase 1 readout · Jan 1, 2026

What's at stake Phase 1 trial results for oral AN2-502998 in Chagas disease are due Jan 1, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 16h ago

“The Company’s Phase 1 first-in-human trial with oral AN2-502998 is nearing completion, with initial clinical data expected in the first quarter of 2026.”

Add to calendar Post on X Reddit

Provenance